Comment/Description - Medical Nutrition USA, Inc.

Borer Financial Communications
Medical Nutrition USA, Inc. - Form 8-K - October 10, 2006
mednutrition.sif, Seq: 1
File Page/Sheet: /
Filename:
mednutrition.sif
Type:
Comment/Description:
(this header is not part of the document)
8-K
NO
NASD
0000722617
*mbwne6i
Borer Financial
201-939-9297
info@borerfinancial.com
jjanco@mnidirect.net
mgans@mnidirect.net
YES
10-10-2006
8.01 9.01

Borer Financial Communications
Medical Nutrition USA, Inc. - Form 8-K - October 10, 2006
medical_8k.txt, Seq: 2
File Page/Sheet: /
Filename:
medical_8k.txt
Type: 8-K
Comment/Description: Form 8-K
(this header is not part of the document)
================================================================================
SECURITIES AND EXCHANGE COMMISSION
UNITED STATES
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 10, 2006
----------------
MEDICAL NUTRITION USA, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-18349 11-3686984
------------------------------ ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of incorporation) File Number) Identification No.)
10 West Forest Avenue
Englewood, New Jersey 07631
---------------------------------------- ----------
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number including area code: (201) 569-1188
--------------
Not Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230 .425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================

Borer Financial Communications
Medical Nutrition USA, Inc. - Form 8-K - October 10, 2006
medical_8k.txt, Seq: 3
File Page/Sheet: /
Item 8.01
Other Events
On October 10, 2006, Medical Nutrition USA, Inc. announced the appointment of
Alan Levy, 44, as Vice President, Finance, Chief Financial Officer, effective
immediately. Mr. Levy was most recently a consultant to public and private
companies in a variety of industries. He is the former Senior Vice President,
Finance, Chief Financial Officer of ATC Healthcare, Inc. where he was
responsible for corporate accounting, financial planning, taxes and SEC filings.
He was previously Corporate Controller and Chief Accounting Officer for Globix
Corp. His prior experience also includes management positions at Del
Laboratories Inc., American Institute of Certified Public Accountants and Ernst
& Young. Mr. Levy is a Certified Public Accountant and received his Bachelor of
Science in Accounting from Long Island University.
Item 9.01
(a)
(b)
(c)
Financial Statements, Pro Forma Financial Information and
Exhibits.
Not applicable
Not applicable
Exhibits:
99.1 Press release dated October 10, 2006.
2

Borer Financial Communications
Medical Nutrition USA, Inc. - Form 8-K - October 10, 2006
medical_8k.txt, Seq: 4
File Page/Sheet: /
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDICAL NUTRITION USA, INC.
Date: October 10, 2006
By: /s/ MYRA GANS
----------------------------------
Executive Vice President/Secretary
3

Borer Financial Communications
Medical Nutrition USA, Inc. - Form 8-K - October 10, 2006
ex99_1.txt, Seq: 5
File Page/Sheet: /
Filename:
ex99_1.txt
Type:
EX-99.1
Comment/Description: Exhibit 99.1
(this header is not part of the document)
EXHIBIT 99.1
--------------------------------------------------------------------------------
Medical Nutrition USA Appoints Chief Financial Officer
--------------------------------------------------------------------------------
ENGLEWOOD, NJ -- October 10, 2006. Medical Nutrition USA, Inc., (MDNU.OB) today
announced the appointment of Alan Levy as Vice President, Finance and Chief
Financial Officer.
"We are extremely pleased to have someone of Alan's competence join our team.
His broad business experience and financial leadership will be invaluable as we
continue to grow", said Frank A. Newman, Chairman and Chief Executive Officer.
Mr. Levy was most recently a consultant to public and private companies in a
variety of industries. He is the former Senior Vice President, Finance, Chief
Financial Officer of ATC Healthcare, Inc. where he was responsible for corporate
accounting, financial planning, taxes and SEC filings. He was previously
Corporate Controller and Chief Accounting Officer for Globix Corp. His prior
experience also includes management positions at Del Laboratories Inc., American
Institute of Certified Public Accountants and Ernst & Young. Mr. Levy is a
Certified Public Accountant and received his Bachelor of Science in Accounting
from Long Island University.
"I am excited to join this team and look forward to the company's continued
success," Mr. Levy said. "Medical Nutrition has developed an enviable reputation
for product innovation and aggressive growth and is very well positioned to be a
leader in its industry."
Medical Nutrition USA, Inc (http://www.mdnu.com) develops and distributes
products for the nutritionally at risk who are under medical supervision. Its
products are used primarily in long-term care facilities, hospitals, dialysis
clinics and bariatric clinics. The company's product lines include Pro-Stat(R),
Fiber-Stat(TM) and the pbs Nutritional Support System(TM), as well as private
label products.
This press release contains forward-looking statements that
are subject to certain risks and uncertainties. Although we believe that the
expectations reflected in any of our forward-looking statements are reasonable,
actual results could differ materially from those projected or assumed. Risks
and uncertainties that could cause or contribute to such material difference
include, but are not limited to, general economic conditions, changes in
customer demand, changes in trends in the nursing home, renal care, health food
and bariatric surgery markets, changes in competitive pricing for products, and
the impact of our competitors' new product introductions. Our future financial
condition and results of operations, as well as any forward-looking statements
are subject to change and inherent risk and uncertainties. Other important
factors that may cause actual results to differ materially from those expressed
in forward-looking statements is contained in the Medical Nutrition USA, Inc.
Annual Report on Form 10-KSB for the year ended January 31, 2006 as filed with
the Securities and Exchange Commission on April 24, 2006 and Form 10-QSB for the
second quarter of fiscal year 2007, filed on September 13, 2006.